{
    "abstract": [],
    "body_text": [
        {
            "text": "Ninety-two patients with CMT from unrelated families were diagnosed by next-generation sequencing (NGS) at the Department of Neurology, Peking University First Hospital from January 2005 to January 2016. ",
            "section": "Patients"
        },
        {
            "text": "Among them, a total of 22 patients with GJB1 mutations were recruited in this study, which comprised 23.9% of the total CMT patients. ",
            "section": "Patients"
        },
        {
            "text": "As for the other CMT genes, the mutation frequency was 35.9% in peripheral myelin protein 22 gene, 17.4% in mitofusin 2 gene, 2.2% in myelin protein zero gene, 5.4% in inverted formin, FH2 and WH2 domain containing (INF2) gene, 4.3% in ganglioside-induced differentiation associated protein 1 gene, 2.2% in neurofilament light gene, 2.2% in periaxin gene, 1.1% in SH3 domain and tetratricopeptide repeats 2 gene, 1.1% in early growth response 2 gene, 1.1% in glycyl-tRNA synthetase gene, 1.1% in leucine rich repeat and sterile alpha motif containing 1 gene, 1.1% in FIG4 phosphoinositide 5-phosphatase (FIG4) gene, 1.1% in alanyl-tRNA synthetase gene, and 1.1% in dehydrogenase E1 and transketolase domain containing 1 gene.",
            "section": "Patients"
        },
        {
            "text": "The clinical records and electrophysiological characteristics of these 22 CMT1X patients with GJB1 mutations were retrospectively collected and reviewed. ",
            "section": "Patients"
        },
        {
            "text": "Muscle weakness was evaluated using the Medical Research Council score. ",
            "section": "Patients"
        },
        {
            "text": "All patients were interviewed and examined by two neurologists.",
            "section": "Patients"
        },
        {
            "text": "Genomic DNA was extracted from the peripheral blood samples of all patients. ",
            "section": "Mutation analysis"
        },
        {
            "text": "Mutations in the GJB1 gene were analyzed by targeted NGS. ",
            "section": "Mutation analysis"
        },
        {
            "text": "NGS panel covered all of the exons and their flanking sequences of genes known to be associated with hereditary neuropathies (gene list available on request). ",
            "section": "Mutation analysis"
        },
        {
            "text": "The exons and their flanking splice sites were captured and subsequently sequenced on an Illumina HiSeq 2500 Sequencer (Illumina, San Diego, CA, USA). ",
            "section": "Mutation analysis"
        },
        {
            "text": "The sequencing files were mapped to reference sequences with BurrowsWheeler Aligner and Picard tools and then called with control samples with the GATK 3.0 HaplotypeCaller (Broad Institute, USA). ",
            "section": "Mutation analysis"
        },
        {
            "text": "Nucleotide alternations were confirmed with Sanger sequencing. ",
            "section": "Mutation analysis"
        },
        {
            "text": "The segregation analyses of the mutations were confirmed in the parents and the affected family members. ",
            "section": "Mutation analysis"
        },
        {
            "text": "For the novel mutations, 1000 healthy controls of Chinese origin were screened. ",
            "section": "Mutation analysis"
        },
        {
            "text": "The biological relevance of the novel amino acid changes was studied using both PolyPhen-2 (http://www. genetics.bwh.harvard.edu/pph2/) and Mutation Taster (http:// www.mutationtaster.org/) programs.",
            "section": "Mutation analysis"
        },
        {
            "text": "These 22 patients came from unrelated families, including 20 males and 2 females. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "The clinical and electrophysiological characteristics of these CMT1X patients are shown in Table 1. ",
            "section": "Patients' clinical and electrophysiological characteristics",
            "ref_spans": [
                {
                    "start": 91,
                    "end": 98,
                    "type": "table",
                    "ref_id": "tab_0",
                    "text": "Table 1"
                }
            ]
        },
        {
            "text": "The mean age of onset was 15.6 \u00b1 8.7 years (ranging from 1 year to 42 years). ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Fifteen (68.2%) patients exhibited first symptoms in their second decade. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Five (22.7%) of them presented symptoms after 20 years old. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Two patients (9.1%) had an earlier onset before 10 years old, including one from infancy. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "The mean duration from onset to diagnostic time was 8.2 \u00b1 4.5 years (ranging from 2 years to 18 years).",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "All patients showed distal muscle wasting and weakness of the lower limbs, with the involvement of the upper limbs in 13 cases. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Muscle strength ranged from III to V in distal upper limbs and from 0 to V in distal lower limbs. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Sensory loss in distal limbs appeared in eight cases. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Pes cavus occurred in 16 cases. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "CNS involvement appeared in five patients (22.7%), including four cases with transient CNS symptoms and one case with constant CNS signs. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "Four cases (18.2%) with transient symptoms presented with sudden onset of cerebral symptoms including aphasia, dysphagia, quadriplegia, or paralysis induced by fever or infection. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "The symptoms usually lasted from hours to days, and the patients completely recovered without special treatment. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "CNS symptoms in two patients appeared initially before the development of peripheral neuropathy. ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "One case with constant CNS involvement additionally presented with nystagmus and ataxia on physical examination.",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "In median nerves, the mean motor nerve conduction velocity (MCV) was 35.0 ",
            "section": "Patients' clinical and electrophysiological characteristics"
        },
        {
            "text": "This study identified 19 different heterozygous mutations in these 22 CMT1X patients [ Table 2   Among 22 patients, the frequency of the GJB1 mutations was 4.5% in transmembrane domain 1 (TM1), 4.5% in TM2, 22.7% in TM3, 9.1% in TM4, 4.5% in extracellular 1 (EC1), 27.3% in EC2, 9.1% in intracellular loop, 13.6% in the N-terminal domain, and 4.5% in the C-terminal domain [ Figure 2].",
            "section": "Gap junction beta-1 protein mutations",
            "ref_spans": [
                {
                    "start": 87,
                    "end": 94,
                    "type": "table",
                    "ref_id": "tab_1",
                    "text": "Table 2"
                },
                {
                    "start": 375,
                    "end": 383,
                    "type": "figure",
                    "ref_id": "fig_2",
                    "text": "Figure 2"
                }
            ]
        },
        {
            "text": "This study confirmed that CMT1X was a common form of inherited neuropathy in Chinese patients with CMT   This study observed that the proportion of CMT1X in Chinese population was greater than other reports. ",
            "section": "discussion"
        },
        {
            "text": "The proportion of CMT1X patients for all CMTs was 10.7% in Europe (n = 997), [21] 15.2% in the USA (n = 527), [22] 12.0% in Australia (n = 224), [23] and 10.9% in Japan (n = 128). ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 81,
                    "type": "bibr",
                    "ref_id": "b21",
                    "text": "[21]"
                },
                {
                    "start": 110,
                    "end": 114,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[22]"
                },
                {
                    "start": 145,
                    "end": 149,
                    "type": "bibr",
                    "ref_id": "b23",
                    "text": "[23]"
                }
            ]
        },
        {
            "text": "[24] In a study of multi-ethnic Malaysian patients with CMTs (n = 25), CMT1X patients were all Chinese and accounted for 24% of the total CMT patients. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[24]"
                }
            ]
        },
        {
            "text": "[25] In this study, all CMT1X patients showed distal muscle weakness predominantly in the lower limbs with a mean onset age of 15.6 \u00b1 8.7 years, similar to other reports. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[25]"
                }
            ]
        },
        {
            "text": "[22] Most patients began presenting their symptoms in their second or third decade. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[22]"
                }
            ]
        },
        {
            "text": "Patients with an earlier onset before 10 years old or in infancy were rare in the present study and other reports. ",
            "section": "discussion"
        },
        {
            "text": "[22,26,27] Electrophysiological findings of our patients further confirmed that CMT1X is an intermediate neuropathy.",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b22",
                    "text": "[22,"
                },
                {
                    "start": 4,
                    "end": 7,
                    "type": "bibr",
                    "ref_id": "b27",
                    "text": "26,"
                },
                {
                    "start": 7,
                    "end": 10,
                    "type": "bibr",
                    "ref_id": "b28",
                    "text": "27]"
                }
            ]
        },
        {
            "text": "Several types of hereditary neuropathies were associated with other organ involvement, such as distal motor neuropathy with optic atrophy, [28] hereditary transthyretin amyloidosis with cardiomyopathy, [29] and dominant inherited intermediate CMT with focal segmental glomerulosclerosis. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 139,
                    "end": 143,
                    "type": "bibr",
                    "text": "[28]"
                },
                {
                    "start": 202,
                    "end": 206,
                    "type": "bibr",
                    "ref_id": "b29",
                    "text": "[29]"
                }
            ]
        },
        {
            "text": "[30] This study confirmed that CNS involvement was common in Chinese CMT1X. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b30",
                    "text": "[30]"
                }
            ]
        },
        {
            "text": "Dysarthria and hemiparesis were the main symptoms of our patients, and other similar symptoms have been occasionally reported in other countries. ",
            "section": "discussion"
        },
        {
            "text": "[31][32][33][34][35][36] CNS symptoms developed after peripheral neuropathy symptoms in some patients in the present study, which has also been reported in previous studies. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b31",
                    "text": "[31]"
                },
                {
                    "start": 4,
                    "end": 8,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "[32]"
                },
                {
                    "start": 8,
                    "end": 12,
                    "type": "bibr",
                    "ref_id": "b33",
                    "text": "[33]"
                },
                {
                    "start": 12,
                    "end": 16,
                    "type": "bibr",
                    "ref_id": "b34",
                    "text": "[34]"
                },
                {
                    "start": 16,
                    "end": 20,
                    "type": "bibr",
                    "ref_id": "b35",
                    "text": "[35]"
                },
                {
                    "start": 20,
                    "end": 24,
                    "type": "bibr",
                    "ref_id": "b36",
                    "text": "[36]"
                }
            ]
        },
        {
            "text": "[32,36] Brain MRIs showed abnormal transient lesions involving bilateral white matter in all patients. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b32",
                    "text": "[32,"
                },
                {
                    "start": 4,
                    "end": 7,
                    "type": "bibr",
                    "ref_id": "b36",
                    "text": "36]"
                }
            ]
        },
        {
            "text": "However, the involvement of the corpus callosum which was frequently reported did not appear in all cases in the present study. ",
            "section": "discussion"
        },
        {
            "text": "[34,37] The isolated involvement of the centrum semiovale, internal capsule, and the periventricular area appeared in the present study as well as in other reports. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b34",
                    "text": "[34,"
                },
                {
                    "start": 4,
                    "end": 7,
                    "type": "bibr",
                    "ref_id": "b37",
                    "text": "37]"
                }
            ]
        },
        {
            "text": "[38,39] We found that the EC2 domain of Cx32 protein was more affected in our patients. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b38",
                    "text": "[38,"
                },
                {
                    "start": 4,
                    "end": 7,
                    "type": "bibr",
                    "ref_id": "b39",
                    "text": "39]"
                }
            ]
        },
        {
            "text": "The EC2 domain was a hotspot mutation domain and was affected in 44% of Korean patients, [40] which was more frequent compared to our patients. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 89,
                    "end": 93,
                    "type": "bibr",
                    "ref_id": "b40",
                    "text": "[40]"
                }
            ]
        },
        {
            "text": "Mutations in the EC1 and EC2 domains of Cx32 were in 65% of the patients with Spanish or Portuguese descent. ",
            "section": "discussion"
        },
        {
            "text": "[41] However, EC1 and EC2 were not hotspot mutation domains in Japanese [24] and Malaysian [25] patients. ",
            "section": "discussion",
            "ref_spans": [
                {
                    "start": 0,
                    "end": 4,
                    "type": "bibr",
                    "ref_id": "b41",
                    "text": "[41]"
                },
                {
                    "start": 72,
                    "end": 76,
                    "type": "bibr",
                    "ref_id": "b25",
                    "text": "[24]"
                },
                {
                    "start": 91,
                    "end": 95,
                    "type": "bibr",
                    "ref_id": "b26",
                    "text": "[25]"
                }
            ]
        },
        {
            "text": "We found no relationship between the position of mutations and CNS involvement in CMT1X. ",
            "section": "discussion"
        },
        {
            "text": "In the present series, mutations of five patients with CNS involvement were located in the N-terminal, TM1, and TM3 domains of GJB1 gene. ",
            "section": "discussion"
        },
        {
            "text": "The c.425G>A mutation was found in patients with pure peripheral neuropathy as well as in patients with additional CNS involvement. ",
            "section": "discussion"
        },
        {
            "text": "Four novel mutations in GJB1 gene were found in our cohort, which expands the spectrum of mutations in CMT1X.",
            "section": "discussion"
        },
        {
            "text": "In summary, CNS impairment was not rare in Chinese CMT1X patients. ",
            "section": "discussion"
        },
        {
            "text": "The CMT1X diagnosis should be considered in children with transient CNS impairment with or without any signs of peripheral neuropathy. ",
            "section": "discussion"
        },
        {
            "text": "Mutations in the EC2 domain of the GJB1 gene were hotspot in Chinese CMT1X patients. ",
            "section": "discussion"
        },
        {
            "text": "We would like to thank the participating patients and their families for their cooperation. ",
            "section": "Acknowledgments"
        },
        {
            "text": "We also thank Ms. Jing Liu, Ms. Yue-Huan Zuo and Ms. Qiu-Rong Zhang for their technical assistance in the preparation of nerve biopsies.",
            "section": "Acknowledgments"
        },
        {
            "text": "This study was supported by a grant from the National Science Foundation of China (No. 81471185).",
            "section": "Financial support and sponsorship"
        },
        {
            "text": "There are no conflicts of interest.",
            "section": "Conflicts of interest"
        }
    ]
}